Literature DB >> 3318303

Tumor cell gangliosides.

S Ladisch1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3318303

Source DB:  PubMed          Journal:  Adv Pediatr        ISSN: 0065-3101


× No keyword cloud information.
  6 in total

1.  Induction of leukocyte infiltration at metastatic site mediates the protective effect of NGcGM3-based vaccine.

Authors:  Mayrel Labrada; Isabel Pablos; Francesca Prete; Giselle Hevia; Marilyn Clavell; Federica Benvenuti; Luis E Fernández
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  Inhibition of human neuroblastoma cell proliferation and EGF receptor phosphorylation by gangliosides GM1, GM3, GD1A and GT1B.

Authors:  B L Mirkin; S H Clark; C Zhang
Journal:  Cell Prolif       Date:  2002-04       Impact factor: 6.831

3.  1H NMR ganglioside ceramide resonance region on the differential diagnosis of low and high malignancy of brain gliomas.

Authors:  V Lombardi; L Valko; M Valko; A Scozzafava; H Morris; M Melnik; J Svitel; M Budesinský; J Pelnár; J Steno; T Liptaj; L Zalibera; J Budinská; J Zlatos; A Giuliani; L Mascolo; D Leibfritz; A Troncone; F Marzullo; M Mazur; J Klener; E Zverina
Journal:  Cell Mol Neurobiol       Date:  1997-10       Impact factor: 5.046

4.  Polysialic acid engineering: synthesis of polysialylated neoglycosphingolipids by using the polysialyltransferase from neuroinvasive Escherichia coli K1.

Authors:  J W Cho; F A Troy
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

Review 5.  Ganglioside modulation of the PDGF receptor. A model for ganglioside functions.

Authors:  A J Yates; H E Saqr; J Van Brocklyn
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

6.  Apoptosis of human breast carcinoma cells in the presence of disialosyl gangliosides: II. Treatment of SKBR3 cells with GD3 and GD1b gangliosides.

Authors:  Rui Ma; Atanas Koulov; Christopher Moulton; Manju Basu; Sipra Banerjee; Holly Goodson; Subhash Basu
Journal:  Glycoconj J       Date:  2004       Impact factor: 3.009

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.